These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 10443041)

  • 21. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for obesity.
    Halford JC
    Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A drug help in reducing? Risk profile decides whether and how].
    Hauner H
    MMW Fortschr Med; 2003 May; 145(21):60. PubMed ID: 12845877
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
    Wirth A
    MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.
    Sari R; Balci MK; Cakir M; Altunbas H; Karayalcin U
    Endocr Res; 2004 May; 30(2):159-67. PubMed ID: 15473126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorrect use of orlistat and sibutramine in clinical practice.
    Dahlin A; Beermann B
    Eur J Clin Pharmacol; 2007 Feb; 63(2):205-9. PubMed ID: 17205321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [No progress without the physician in therapy of obesity].
    Schmidt H; Plauth M
    MMW Fortschr Med; 2000 Jan; 142(4):35-6. PubMed ID: 10850095
    [No Abstract]   [Full Text] [Related]  

  • 29. Safe and effective management of the obese patient.
    Collazo-Clavell ML
    Mayo Clin Proc; 1999 Dec; 74(12):1255-9; quiz 1259-60. PubMed ID: 10593355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
    Coutinho W
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What effect does losing weight have on hypertension?].
    Engeli S
    MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.
    Gursoy A; Erdogan MF; Cin MO; Cesur M; Baskal N
    Eat Weight Disord; 2006 Dec; 11(4):e127-32. PubMed ID: 17272944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging strategies for weight management. Summary.
    Hansen BC
    Postgrad Med; 2001 Jun; 109(6 Suppl):40-4. PubMed ID: 19667567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
    Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
    Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Weight loss via drug therapy].
    Wirth A
    Internist (Berl); 2003 Mar; 44(3):359-62, 363-6. PubMed ID: 12731423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 39. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
    García Díaz E; Martín Folgueras T
    Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What role for weight-loss medication? Weighing the pros and cons for obese patients.
    Wyatt HR; Hill JO
    Postgrad Med; 2004 Jan; 115(1):38-40, 43-5, 58. PubMed ID: 14755876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.